PYY3‐36 as an anti‐obesity drug target
Year: 2005
Type: review
Source: Obesity Reviews
Authors: M. M. Boggiano, P. C. Chandler, K. D. Oswald, R. J. Rodgers, J. E. Blundell, Y. Ishii, A. H. Beattie, P. Holch, D. B. Allison, M. Schindler, K. Arndt, K. Rudolf, M. Mark, C. Schoelch, H. G. Joost, S. Klaus, C. Thöne‐Reineke, S. C. Benoit, R. J. Seeley, A. G. Beck‐Sickinger, N. Koglin, K. Raun, K. Madsen, B. S. Wulff, C. E. Stidsen, M. Birringer, O. J. Kreuzer, X. Y. Deng, D. C. Whitcomb, H. Halem, J. Taylor, J. Dong, R. Datta, M. Culler, S. Ortmann, T. R. Castañeda, M. Tschöp
Institutions: University of Alabama at Birmingham, University of Leeds, Boehringer Ingelheim (Germany), German Institute of Human Nutrition, Charité – Universitätsmedizin Berlin, University of Cincinnati, Leipzig University, Novo Nordisk (Denmark), University of Pittsburgh, Ipsen (France), Ipsen (United States), Leibniz Institute for Zoo and Wildlife Research
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2114359174
